CARDINAL HEALTH INC

Cardinal Health’s robust $54.6B market cap and $239.23 closing price showcase its strategic diversification across pharma distribution, automated dispensing, and retail pharmacy franchising, positioning it as a leading innovator in healthcare soluti…

Cardinal Health dominates the healthcare supply chain, expanding logistics, fulfillment, and pharma solutions while weathering investor shifts, ensuring robust growth and innovation.

Cardinal Health’s strong market position, $53 bn cap, and tech‑driven pharma innovations keep investors focused on its steady growth and future potential.

Cardinal Health’s resilient market cap and diverse pharmacy‑distribution portfolio underscore its pivotal role in U.S. healthcare, with a 2025 stock still near its 52‑week peak.

Cardinal Health Q1 beats estimates with 22% revenue growth, boosts EPS outlook, and hits a new 52‑week high—investors see strong value‑added upside.

Cardinal Health, Inc. has demonstrated a significant recovery in its stock performance, driven by its diversified business model, strategic innovations, and global expansion efforts, positioning the company as a critical component in the healthcare …

Cardinal Health Inc. reports strong Q4 and FY2025 results, raises FY2026 guidance, and makes a strategic acquisition of Solaris Health, positioning the company for continued growth and leadership in the healthcare sector.

Cardinal Health Inc. has announced a strong financial outlook, including a 13% projected growth in earnings, and strategic partnerships that position the company for sustained growth and value creation in the healthcare industry.

Cardinal Health Inc. reported a strong third-quarter performance, exceeding expectations with a 19% revenue increase and raising its adjusted earnings guidance for fiscal year 2025.

Cardinal Health Inc. has demonstrated significant growth over the past decade, with its shares increasing by 52.03% in value, and is well-positioned for continued success in the healthcare sector.